Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, N
Recalled August 6, 2025 · FDA recall D-0551-2025 · Hikma Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds · FDA Class II
Units
382,775 1mL vials
Sold at
Distributed Nationwide in the USA
Description
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Product
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Manufacturer(s)
Hikma Pharmaceuticals USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →